Press release from Companies: WntResearch has received an approval on its patent application from the Canadian patent office for its drug candidate Box-5

Press release from Companies: WntResearch has received an approval on its patent application from the Canadian patent office for its drug candidate Box-5

Press release from Companies: WntResearch use a share trading service to support a more stable trade of the company's stock.

Press release from Companies: WntResearch utnyttjar aktiehandelstjänst för att stimulera till en stabilare handel i bolagets aktie

Press release from Companies: WntResearch utnyttjar aktiehandelstjänst för att stimulera till en stabilare handel i bolagets aktie

Press release from Companies: WntResearch utnyttjar aktiehandelstjänst för att stimulera till en stabilare handel i bolagets aktie

More from the company: Ny forskning ger ökad kunskap om verkningsmekanismen för det kroppsegna proteinet Wnt-5a och dess roll i kroppens försvar mot bröstcancer

More from the company: Ny forskning ger ökad kunskap om verkningsmekanismen för det kroppsegna proteinet Wnt-5a och dess roll i kroppens försvar mot bröstcancer

More from the company: Ny forskning ger ökad kunskap om verkningsmekanismen för det kroppsegna proteinet Wnt-5a och dess roll i kroppens försvar mot bröstcancer

More from the company: New research provides further insights on the mechanisms of Wnt-5a and its role in the human body's defence system against breast cancer.

More from the company: New research provides further insights on the mechanisms of Wnt-5a and its role in the human body's defence system against breast cancer.

Reports: Delårsrapport Q2 april - juni 2016